神经退行性变、突触功能障碍与胶质增生是阿尔茨海默痴呆的表型特征
横断面研究纳入79名70岁以上成人,按诊断和p-tau/Aβ42分为对照组、AD痴呆组和不匹配组,比较神经退行性变、突触功能障碍和胶质激活标志物。不匹配组p-tau/Aβ42和Aβ42/Aβ40与AD痴呆组相当,但NFL和总tau显著更低,YKL-40和神经颗粒素与AD痴呆组无显著差异且与对照组无显著差异。结论提示无显著神经退行性过程时,携带AD神经病理者可能保持认知正常。
要点
- 不匹配组p-tau/Aβ42和Aβ42/Aβ40与AD痴呆组相当。
- 不匹配组NFL和总tau显著低于AD痴呆组。
- 不匹配组YKL-40和神经颗粒素与AD痴呆组及对照组均无显著差异。
核心结论
- 结果表明,在缺乏显著神经退行性过程的情况下,携带AD神经病理的个体可能保持认知正常。
研究设计与样本
- 横断面研究纳入79名70岁以上成人(年龄77.1±5.3岁),进行综合认知评估和脑脊液采集。
- 按诊断和p-tau/Aβ42分为三组:低p-tau/Aβ42且认知正常为对照组(n=25);高p-tau/Aβ42且诊断为AD痴呆或AD轻度认知障碍为AD痴呆组(n=40);高p-tau/Aβ42但认知正常为不匹配组(n=14)。
- 另进行无年龄排除标准的二次分析(n=411)。
主要发现
- 不匹配组p-tau/Aβ42和Aβ42/Aβ40水平与AD痴呆组相当。
- 不匹配组NFL和总tau水平显著低于AD痴呆组。
- 不匹配组YKL-40和神经颗粒素与AD痴呆组无显著差异,与对照组也无显著差异。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To test the hypothesis that cognitively unimpaired individuals with Alzheimer disease (AD) neuropathology differ from individuals with AD dementia on biomarkers of neurodegeneration, synaptic dysfunction, and glial activation. METHODS: In a cross-sectional study, adult participants >70 years old (n = 79, age 77.1 ± 5.3 years) underwent comprehensive cognitive evaluation and CSF collection, which was assayed for markers of amyloid, phosphorylated tau (p-tau), neurodegeneration (neurofilament light protein [NFL] and total tau), synaptic dysfunction (neurogranin), and glial activation (chitinase-3-like protein 1 [YKL-40]). Participants were divided into 3 groups based on diagnosis and p-tau/β-amyloid42 (Aβ42): those with low p-tau/Aβ42 and unimpaired cognition were classified as controls (n = 25); those with high p-tau/Aβ42 diagnosed with AD-dementia or AD-mild cognitive impairment were classified as AD-Dementia (n = 40); and those with high p-tau/Aβ42 but unimpaired cognition were classified as mismatches (n = 14). A similar, secondary analysis was performed with no age exclusion criteria (n = 411). RESULTS: In both the primary and secondary analyses, biomarker levels between groups were compared with the use of analysis of covariance while controlling for age and demographic variables. Despite p-tau/Aβ42 and Aβ42/Aβ40 levels comparable to those of the AD-Dementia group, mismatches had significantly lower levels of NFL and total tau. While not significantly lower than the AD-Dementia group on YKL-40 and neurogranin, mismatches were also not significantly different from controls. CONCLUSIONS: These results provide evidence that, in the absence of significant neurodegenerative processes, individuals who harbor AD neuropathology may remain cognitively unimpaired. This finding provides insight into the biological processes phenotypic of dementia and supports monitoring multiple biomarkers in individuals positive for AD neuropathology.
引用
- Merluzzi AP, Carlsson CM, Johnson SC, et al. Neurodegeneration, synaptic dysfunction, and gliosis are phenotypic of Alzheimer dementia. Neurology. 2018. PMID: 29959263. doi:10.1212/WNL.0000000000005901
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。